ORal anticoaGulants in diAbetic and Nondiabetic Patients With nOn-valvular Atrial fibrillatioN (ORGANON)

Overview

Diabetic and nondiabetic patients will be evaluated if they had a first diagnosis of non-valvular atrial fibrillation and in therapy with non-vitamin K oral anticoagulants and with vitamin K oral anticoagulants.

Parameters evaluated: * anthropometric indices * glycated haemoglobin, basal and postprandial glycemia * lipid profile * small and dense LDL; oxidized LDL * I troponin * red and white cells count; platelets count * creatinin, transaminases, iron * fibrinogen, D-dimer, anti-thrombin III * Hs-CRP, metalloproteinases 2 and 9 * incidence of bleeding

Conditions

Interventions

Eligibility

Locations (1)

Outcomes